These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 11259142)

  • 1. Update on atrial remodelling owing to rate; does atrial fibrillation always 'beget' atrial fibrillation?
    Pandozi C; Santini M
    Eur Heart J; 2001 Apr; 22(7):541-53. PubMed ID: 11259142
    [No Abstract]   [Full Text] [Related]  

  • 2. [Atrial fibrillation successfully converted. A new standard in the prevention of recurrence?].
    Fetsch T
    MMW Fortschr Med; 2001 Dec; 143(51-52):10-2. PubMed ID: 11824159
    [No Abstract]   [Full Text] [Related]  

  • 3. [The atrial electrical remodeling in atrial fibrillation].
    Niwano S
    Nihon Rinsho; 2002 Jul; 60(7):1308-16. PubMed ID: 12136608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacologic treatment of atrial fibrillation].
    Lelakowski J
    Pol Merkur Lekarski; 2008 Oct; 25(148):303-8. PubMed ID: 19145926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrial fibrillation: beyond "irregularly irregular".
    Josephson L; McMullen M
    Nurs Manage; 2003; 34 Suppl Critical():4-10. PubMed ID: 12891080
    [No Abstract]   [Full Text] [Related]  

  • 6. Electropharmacological effects of antiarrhythmic drugs on atrial fibrillation termination. Part I: Molecular and ionic fundamentals of antiarrhythmic drug actions.
    Calò L; Sciarra L; Lamberti F; Loricchio ML; Castro A; Bianconi L; Pandozi C; Gaita F; Santini M
    Ital Heart J; 2003 Jul; 4(7):430-41. PubMed ID: 14558293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Non-channel drugs to prevent atrial fibrillation].
    Fazekas T; Liszkai G
    Orv Hetil; 2005 Nov; 146(45):2287-94. PubMed ID: 16304807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular basis of remodelling in atrial fibrillation].
    Dobrev D
    Dtsch Med Wochenschr; 2004 Apr; 129(15):827-30. PubMed ID: 15054689
    [No Abstract]   [Full Text] [Related]  

  • 9. [Atrial fibrillation--treatment].
    Jung J; Böhm M
    Dtsch Med Wochenschr; 2001 Dec; 126(51-52):1472-5. PubMed ID: 11753741
    [No Abstract]   [Full Text] [Related]  

  • 10. Management of atrial fibrillation by Canadian electrophysiologists after early termination of the PALLAS study.
    Mohajer K; Fregeau B; Garg V; Skanes A; Simpson CS; Redfearn DP; Michael KA; Baranchuk A
    Can J Cardiol; 2013 Jan; 29(1):131.e1-2. PubMed ID: 23026474
    [No Abstract]   [Full Text] [Related]  

  • 11. Can short-term verapamil therapy reduce the recurrence of atrial fibrillation after successful low energy intracardiac cardioversion?
    Zardo F; Antonini-Canterin F; Brieda M; Hrovatin E; Pavan D; Burelli C; Cervesato E; Nicolosi GL
    Ital Heart J; 2001 Jul; 2(7):513-8. PubMed ID: 11501960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel pharmacological therapies for atrial fibrillation.
    Bagwe S; Leonardi M; Bissett J
    Curr Opin Cardiol; 2007 Sep; 22(5):450-7. PubMed ID: 17762547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Verapamil and diltiazem in the treatment of atrial fibrillation].
    Iagenskiĭ VA; Grosu AA
    Ter Arkh; 1997; 69(8):58-60. PubMed ID: 9381395
    [No Abstract]   [Full Text] [Related]  

  • 14. Termination of atrial fibrillation by flecainide: mechanistic insights from spectral analysis.
    Hunter RJ; Schilling RJ
    Europace; 2010 Apr; 12(4):453-4. PubMed ID: 20167613
    [No Abstract]   [Full Text] [Related]  

  • 15. Electropharmacological effects of antiarrhythmic drugs on atrial fibrillation termination. Part II: New insights into the electrophysiological mechanisms of atrial fibrillation termination.
    Calò L; Sciarra L; Lamberti F; Loricchio ML; Castro A; Bianconi L; Pandozi C; Gaita F; Santini M
    Ital Heart J; 2003 Jul; 4(7):442-7. PubMed ID: 14558294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Atrial fibrillation: rhythm or rate control?].
    Le Heuzey JY; Saïd MA; Paziaud O
    Rev Prat; 2002 Jun; 52(12):1335-8. PubMed ID: 12187898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rate control for atrial fibrillation: one drug or two?
    Segal OR
    Postgrad Med J; 2009 Jun; 85(1004):281-2. PubMed ID: 19528299
    [No Abstract]   [Full Text] [Related]  

  • 18. Rate control in atrial fibrillation.
    Dorian P
    N Engl J Med; 2010 Apr; 362(15):1439-41. PubMed ID: 20231233
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of oral L-type calcium channel blocker on repetitive paroxysmal atrial fibrillation: spectral analysis of fibrillation waves in the Holter monitoring.
    Niwano S; Fukaya H; Sasaki T; Hatakeyama Y; Fujiki A; Izumi T
    Europace; 2007 Dec; 9(12):1209-15. PubMed ID: 17897926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. BET 2: are calcium channel blockers superior to digoxin for controlling the ventricular rate in patients with acute atrial fibrillation?
    Parris RJ; Clarke SF
    Emerg Med J; 2009 Dec; 26(12):881-3. PubMed ID: 19934136
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.